|
In terms of the number of people
affected, neurological diseases that contributed to decline in
neuronal function are sometimes considered the newest healthcare
epidemic. With the number of cases of neurodegenerative conditions
expected to grow dramatically, driven by the aging population in
developed countries, this therapeutic area represents one of the
most compelling in both commercial and human terms. But the past few
decades have been marked by optimistic pronouncements followed by
clinical disappointments. As advances in genetics and target
identification increase our understanding of the physiological basis
of disease and cellular medicine, the search for a solution to
neuronal protection is reaching into new clinical areas.
Publication Date:
May 2008 |
